1
|
Bakbak E, Krishnaraj A, Bhatt DL, Quan A, Park B, Bakbak AI, Bari B, Terenzi KA, Pan Y, Fry EJ, Terenzi DC, Puar P, Khan TS, Rotstein OD, Mazer CD, Leiter LA, Teoh H, Hess DA, Verma S. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial. MED 2024; 5:718-734.e4. [PMID: 38552629 DOI: 10.1016/j.medj.2024.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 02/19/2024] [Accepted: 03/11/2024] [Indexed: 07/15/2024]
Abstract
BACKGROUND REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial) showed that icosapent ethyl (IPE) reduced major adverse cardiovascular events by 25%. Since the underlying mechanisms for these benefits are not fully understood, the IPE-PREVENTION CardioLink-14 trial (ClinicalTrials.gov: NCT04562467) sought to determine if IPE regulates vascular regenerative (VR) cell content in people with mild to moderate hypertriglyceridemia. METHODS Seventy statin-treated individuals with triglycerides ≥1.50 and <5.6 mmol/L and either atherosclerotic cardiovascular disease or type 2 diabetes with additional cardiovascular risk factors were randomized to IPE (4 g/day) or usual care. VR cells with high aldehyde dehydrogenase activity (ALDHhi) were isolated from blood collected at the baseline and 3-month visits and characterized with lineage-specific cell surface markers. The primary endpoint was the change in frequency of pro-vascular ALDHhiside scatter (SSC)lowCD133+ progenitor cells. Change in frequencies of ALDHhiSSCmid monocyte and ALDHhiSSChi granulocyte precursor subsets, reactive oxygen species production, serum biomarkers, and omega-3 levels were also evaluated. FINDINGS Baseline characteristics, cardiovascular risk factors, and medications were balanced between the groups. Compared to usual care, IPE increased the mean frequency of ALDHhiSSClowCD133+ cells (-1.00% ± 2.45% vs. +7.79% ± 1.70%; p = 0.02), despite decreasing overall ALDHhiSSClow cell frequency. IPE assignment also reduced oxidative stress in ALDHhiSSClow progenitors and increased ALDHhiSSChi granulocyte precursor cell content. CONCLUSIONS IPE-PREVENTION CardioLink-14 provides the first translational evidence that IPE can modulate VR cell content and suggests a novel mechanism that may underlie the cardioprotective effects observed with IPE in REDUCE-IT. FUNDING HLS Therapeutics provided the IPE in kind and had no role in the study design, conduct, analyses, or interpretation.
Collapse
Affiliation(s)
- Ehab Bakbak
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
| | - Aishwarya Krishnaraj
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
| | - Deepak L Bhatt
- Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Adrian Quan
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada
| | - Brady Park
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
| | | | - Basel Bari
- Markham Health+ Plex, Markham, ON, Canada
| | | | - Yi Pan
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada
| | | | | | - Pankaj Puar
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
| | - Tayyab S Khan
- Division of Endocrinology and Metabolism, St. Joseph's Healthcare Centre, London, ON, Canada; Department of Medicine, Western University, London, ON, Canada
| | - Ori D Rotstein
- Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Division of General Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Department of Surgery, University of Toronto, Toronto, ON, Canada
| | - C David Mazer
- Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Department of Anesthesia, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada; Department of Physiology, University of Toronto, Toronto, ON, Canada
| | - Lawrence A Leiter
- Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Division of Endocrinology and Metabolism, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Department of Medicine, University of Toronto, Toronto, ON, Canada; Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada
| | - Hwee Teoh
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Division of Endocrinology and Metabolism, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada
| | - David A Hess
- Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Department of Physiology and Pharmacology, Western University, London, ON, Canada; Molecular Medicine Research Labs, Robarts Research Institute, London, ON, Canada.
| | - Subodh Verma
- Division of Cardiac Surgery, St. Michael's Hospital of Unity Health Toronto, Toronto, ON, Canada; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Department of Surgery, University of Toronto, Toronto, ON, Canada.
| |
Collapse
|
2
|
Arlat A, Renoud ML, Nakhle J, Thomas M, Fontaine J, Arnaud E, Dray C, Authier H, Monsarrat P, Coste A, Casteilla L, Ousset M, Cousin B. Generation of functionally active resident macrophages from adipose tissue by 3D cultures. Front Immunol 2024; 15:1356397. [PMID: 38975341 PMCID: PMC11224291 DOI: 10.3389/fimmu.2024.1356397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2023] [Accepted: 05/31/2024] [Indexed: 07/09/2024] Open
Abstract
Introduction Within adipose tissue (AT), different macrophage subsets have been described, which played pivotal and specific roles in upholding tissue homeostasis under both physiological and pathological conditions. Nonetheless, studying resident macrophages in-vitro poses challenges, as the isolation process and the culture for extended periods can alter their inherent properties. Methods Stroma-vascular cells isolated from murine subcutaneous AT were seeded on ultra-low adherent plates in the presence of macrophage colony-stimulating factor. After 4 days of culture, the cells spontaneously aggregate to form spheroids. A week later, macrophages begin to spread out of the spheroid and adhere to the culture plate. Results This innovative three-dimensional (3D) culture method enables the generation of functional mature macrophages that present distinct genic and phenotypic characteristics compared to bone marrow-derived macrophages. They also show specific metabolic activity and polarization in response to stimulation, but similar phagocytic capacity. Additionally, based on single-cell analysis, AT-macrophages generated in 3D culture mirror the phenotypic and functional traits of in-vivo AT resident macrophages. Discussion Our study describes a 3D in-vitro system for generating and culturing functional AT-resident macrophages, without the need for cell sorting. This system thus stands as a valuable resource for exploring the differentiation and function of AT-macrophages in vitro in diverse physiological and pathological contexts.
Collapse
Affiliation(s)
- Adèle Arlat
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Marie-Laure Renoud
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Jean Nakhle
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Miguel Thomas
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Jessica Fontaine
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Emmanuelle Arnaud
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Cédric Dray
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Hélène Authier
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Paul Monsarrat
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
- Dental Faculty and Hospital of Toulouse – Toulouse Institute of Oral Medicine and Science, CHU de Toulouse, Toulouse, France
- Artificial and Natural Intelligence Toulouse Institute (ANITI), Toulouse, France
| | - Agnès Coste
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Louis Casteilla
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Marielle Ousset
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| | - Béatrice Cousin
- RESTORE Research Center, Université de Toulouse, INSERM 1301, CNRS 5070, Etablissement Français du Sang (EFS), Ecole Nationale Vétérinaire de Touloue (ENVT), Toulouse, France
| |
Collapse
|
3
|
Ortega-Gomez A, Lopez S, Varela LM, Jaramillo S, Muriana FJ, Abia R. New evidence for dietary fatty acids in the neutrophil traffic between the bone marrow and the peripheral blood. FOOD CHEMISTRY. MOLECULAR SCIENCES 2022; 5:100133. [PMID: 36111060 PMCID: PMC9467871 DOI: 10.1016/j.fochms.2022.100133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 09/02/2022] [Accepted: 09/03/2022] [Indexed: 11/11/2022]
Abstract
Chronic administration of a high-fat diet in mice has been established to influence the generation and trafficking of immune cells such as neutrophils in the bone marrow, the dysregulation of which may contribute to a wide range of diseases. However, no studies have tested the hypothesis that a short-term, high-fat diet could early modulate the neutrophil release from bone marrow at fasting and at postprandial in response to a high-fat meal challenge, and that the predominant type of fatty acids in dietary fats could play a role in both context conditions. Based on these premises, we aimed to establish the effects of different fats [butter, enriched in saturated fatty acids (SFAs), olive oil, enriched in monounsaturated fatty acids (MUFAs), and olive oil supplemented with eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids] on neutrophil navigation from bone marrow to blood in mice. The analysis of cellular models for mechanistic understanding and of postprandial blood samples from healthy volunteers for translational purposes was assessed. The results revealed a powerful effect of dietary SFAs in promotion the neutrophil traffic from bone marrow to blood via the CXCL2-CXCR2 axis. Dietary SFAs, but not MUFAs or EPA and DHA, were also associated with increased neutrophil apoptosis and bone marrow inflammation. Similar dietary fatty-acid-induced postprandial neutrophilia was observed in otherwise healthy humans. Therefore, dietary MUFAs might preserve bone marrow health and proper migration of bone marrow neutrophils early in the course of high-fat diets even after the intake of high-fat meals.
Collapse
Key Words
- BMSF, bone marrow supernatant fluid
- Bone marrow inflammation
- Butter
- Ct, threshold cycle
- DHA, docosahexaenoic acid
- Dietary fatty acids
- EPA, eicosapentaenoic acid
- FACS, fluorescence-activated cell sorting
- FSC, forward scatter
- HBSS, Hank’s balance salt solution
- HFDs, high-fat diets
- HSCs, hematopoietic stem cells
- High-fat diets
- LFD, low-fat diet
- MFI, mean fluorescence intensity
- MMP9, matrix metalloproteinase 9
- MUFAs, monounsaturated fatty acids
- Neutrophil mobilisation
- OCM, oral control meal
- OFLs, oral fat loads
- OFMs, oral fat meals
- OSL, oral saline load
- Olive oil
- PI, propidium iodide
- PUFAs, polyunsaturated fatty acids
- SFAs, saturated fatty acids
- SSC, side scatter
- TRLs, triglyceride-rich lipoproteins
- qRT-PCR, quantitative real-time reverse transcription polymerase chain reaction
Collapse
Affiliation(s)
- Almudena Ortega-Gomez
- Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, The Spanish National Research Council (CSIC), 41013 Seville, Spain
- Department of Cellular and Molecular Endocrinology, Instituto de Investigacion Biomedica de Malaga (IBIMA), Virgen de la Victoria University Hospital, 29010 Malaga, Spain
| | - Sergio Lopez
- Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, The Spanish National Research Council (CSIC), 41013 Seville, Spain
- Department of Cell Biology, Faculty of Biology, University of Seville, 41012 Seville, Spain
- Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/University of Seville, 41013 Seville, Spain
| | - Lourdes M. Varela
- Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, The Spanish National Research Council (CSIC), 41013 Seville, Spain
- Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/University of Seville, 41013 Seville, Spain
- Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, 41009 Seville, Spain
| | - Sara Jaramillo
- Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, The Spanish National Research Council (CSIC), 41013 Seville, Spain
| | - Francisco J.G. Muriana
- Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, The Spanish National Research Council (CSIC), 41013 Seville, Spain
| | - Rocio Abia
- Laboratory of Cellular and Molecular Nutrition, Instituto de la Grasa, The Spanish National Research Council (CSIC), 41013 Seville, Spain
| |
Collapse
|